Arvinas and Pfizer announce initial Phase 1b Data from the TACTIVE-U sub-study of Vepdegestrant in…
Vepdegestrant in combination with abemaciclib demonstrated encouraging clinical activity (clinical benefit rate: 62.5 per cent;…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
breast cancer drug
AstraZeneca’s breast cancer drug combination fails in late-stage trial
The trial, known as CAPItello-290, was testing whether the drug combination improved overall survival in patients
Alkem launches breast cancer treatment drug palbociclib (Palbo) in India
The drug comes in capsule form in multiple dose strengths with varied pricing ranges, including 125 mg at Rs 6,125/- for 21…
Dr Reddy’s launches in-house palbociclib to widen access to breast cancer drug
Dr Reddy's is among select companies to have conducted bioequivalence study, and has already received tentative approval from the…
Eli Lilly introduces Ramiven (abemaciclib) in India
Abemaciclib is a CDK4/6 inhibitor which has now been approved for HR+ HER2 - node positive high-risk Early Breast Cancer (EBC)
Zydus Cadila receives tentative USFDA approval for palbociclib capsules
It is an anti-cancer medicine that interferes with the growth and spread of cancer cells in the body